Age-Related Macular Degeneration and Diabetic Retinopathy are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.
Age-Related Macular Degeneration vs Diabetic Retinopathy at a glance
Age-Related Macular Degeneration: Central retinal degeneration — dry (atrophic) and wet (neovascular) forms; leading cause of central vision loss in older adults.
Diabetic Retinopathy: Microvascular retinal disease from chronic hyperglycemia — leading cause of new-onset blindness in working-age adults.
Try two board-style questions on Age-Related Macular Degeneration vs Diabetic Retinopathy
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1EENTMedium
A 68-year-old male has progressive painless decreased central vision over 2 years. Amsler grid shows distortion of straight lines. Funduscopy shows numerous large drusen and pigmentary changes in the macula bilaterally without hemorrhage or exudate. Which of the following is the most appropriate initial management?
AAREDS-2 vitamin supplementation
BIntravitreal anti-VEGF injection
CPhotodynamic laser therapy
DOral omega-3 supplements
Reveal answer & full explanation
Correct answer: A — AREDS-2 vitamin supplementation
AAREDS-2 vitamin supplementation✓
BIntravitreal anti-VEGF injection
CPhotodynamic laser therapy
DOral omega-3 supplements
Why AREDS-2 vitamin supplementation is correct
This patient has dry (atrophic) age-related macular degeneration (AMD): drusen with retinal pigment epithelium (RPE) changes and gradual central vision loss without neovascularization
Age-Related Eye Disease Study 2 (AREDS-2) supplementation — vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin — reduces progression to advanced AMD by approximately 25%
Smoking cessation and a healthy diet are also recommended
Home Amsler grid monitoring is important; sudden new distortion may signal conversion to wet AMD
Why the others are wrong
Intravitreal anti-VEGF injection — anti-vascular endothelial growth factor (anti-VEGF) agents such as ranibizumab, aflibercept, and bevacizumab are reserved for wet (neovascular) AMD, which involves choroidal neovascularization; not indicated for dry AMD
Photodynamic laser therapy — verteporfin photodynamic therapy treats choroidal neovascularization (now largely replaced by anti-VEGF) and has no role in dry AMD, which has no neovascular lesion to treat
Oral omega-3 supplements — AREDS2 found that adding omega-3 fatty acids (DHA and EPA) to the AREDS formulation did not further reduce progression to advanced AMD, so they are not recommended for this purpose
Question 2EENTMedium
A 54-year-old man with a 19-year history of poorly controlled type 2 diabetes mellitus (most recent A1c 10.4%) reports new floaters and intermittent blurred vision in the right eye. Dilated fundus examination shows scattered dot-blot hemorrhages, venous beading, and a tuft of fragile new vessels arising from the optic disc. Fluorescein angiography demonstrates extensive areas of peripheral capillary nonperfusion with leakage from the disc neovascularization. Which of the following best explains the findings?
AComplement-mediated drusen accumulation beneath the retinal epithelium
BLipohyalinosis of retinal arterioles from chronic systemic hypertension
Why Ischemia-driven VEGF upregulation driving retinal neovascularization is correct
Chronic hyperglycemia damages retinal capillary pericytes and endothelial cells, producing microaneurysms, increased permeability, and progressive capillary nonperfusion (ischemia).
Widespread retinal ischemia upregulates vascular endothelial growth factor (VEGF), which drives the fragile new vessels at the disc (NVD) that define proliferative diabetic retinopathy.
The angiographic finding of extensive peripheral capillary nonperfusion plus leaking disc neovascularization is the hallmark of this VEGF-mediated pathway, which is why panretinal photocoagulation and anti-VEGF therapy are effective.
Why the others are wrong
Immune complex deposition causing inflammatory retinal vasculitis underlies autoimmune or infectious vasculitis (e.g., lupus, Behcet) rather than the metabolic microvascular injury and ischemic VEGF drive of diabetic retinopathy.
Lipohyalinosis of retinal arterioles from chronic systemic hypertension describes hypertensive retinopathy (AV nicking, copper/silver wiring, flame hemorrhages) and does not produce the ischemia-driven disc neovascularization seen here.
Complement-mediated drusen accumulation beneath the retinal epithelium is the mechanism of age-related macular degeneration, a sub-retinal process unrelated to the diabetic ischemia-VEGF axis that drives neovascularization.
🔒 Free preview limit reached
Keep comparing — start your free trial
You've used your 2 free previews. Create your free account to see the full Age-Related Macular Degeneration vs Diabetic Retinopathy comparison — plus all 514 diagnosis outlines, 7,200+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.
Central retinal degeneration — dry (atrophic) and wet (neovascular) forms; leading cause of central vision loss in older adults.
Microvascular retinal disease from chronic hyperglycemia — leading cause of new-onset blindness in working-age adults.
Classic presentation
Drusen on fundoscopy in dry AMD; sudden metamorphopsia with subretinal fluid and hemorrhage in wet AMD.; Dry AMD: gradual painless central blurring, difficulty reading, central scotomas; often asymptomatic early; Wet AMD: SUDDEN-onset central distortion (metamorphopsia — straight lines look wavy), central scotoma, or decline in vision…
Dot-blot hemorrhages with hard exudates and microaneurysms in a diabetic; neovascularization of the disc (NVD) in PDR.; Often ASYMPTOMATIC until advanced or DME develops — emphasizes screening; Blurred or fluctuating vision (often with glycemic swings); Floaters or sudden vision loss — vitreous hemorrhage from PDR; Curtain over vision —…
Workup / key labs
Not routinely indicated for diagnosis
ADA / AAO screening: dilated exam at diagnosis in type 2 DM and within 5 years of diagnosis in type 1 (and at puberty), then annually (or every 1-2 years if no retinopathy and good glycemic control). Pregnant diabetic patients: exam in first trimester and as indicated.; A1c, lipid panel, BMP, urine albumin-creatinine — for diabetic…
Imaging
Dilated fundus examination; Optical coherence tomography (OCT) — primary imaging modality; detects intraretinal/subretinal fluid, drusen, RPE elevation, geographic atrophy; OCT angiography (OCTA) — non-invasive detection of CNV; Fluorescein angiography — gold standard for CNV; defines lesion type (classic vs occult); Indocyanine green…
Smoking cessation — modifiable risk factor with strongest evidence; Mediterranean-style diet rich in leafy greens, fish (omega-3), and colored fruits; Cardiovascular risk factor management (blood pressure, lipids, weight); UV protection with sunglasses is reasonable but unproven (evidence linking sunlight to AMD is inconsistent); Amsler…
Optimize glycemic control — target A1c individualized but typically <7% (DCCT, UKPDS); Blood pressure control — typically <130/80 per ADA Standards of Care (UKPDS showed BP lowering slows DR progression); Lipid management — statin per ASCVD guidelines; fenofibrate has independent benefit on DR progression (ACCORD Eye, FIELD); Smoking…
Drill Age-Related Macular Degeneration vs Diabetic Retinopathy questions on FirstPassPA
Turn this comparison into retention. 7,200+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.